.jpg)
.png)
All
Thank you for your contribution. Your data will be viewed by our staff and posted on our website within 24 hours. <<Go back to the Career Center <<Go back to the Community <<Go back to the Photo Galleries <<Go back to the Mentoring Program
The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse cardiovascular events (MACE) in primary prevention populations. The study synthesizes data from randomized... more
Risk assessment tools and lifestyle surveys can play a major role in screening patients for risk of atherosclerotic cardiovascular disease (ASCVD), allowing for early targeted interventions. It is known that race can greatly impact risk, yet it isn’t incorporated in all risk calculators. Similarly... more
Pittsburgh — Today, the National Lipid Association (NLA) published its Part Two Recommendations based on a panel of independent experts, available now on the Journal of Clinical Lipidology website. Part Two of the NLA Recommendations reinforce the importance of lifestyle... more
Thank you for attending the NLA Lipid University. We hope you were able to take home key points and broaden your knowledge in the lipidology field. For your convenience, below are the slide decks in PDF format if you wish to review further. more
The National Lipid Association's campaign for National Cholesterol Education Month is a social-media focused initiative to raise awareness about the importance of cholesterol management and its impact on cardiovascular health. Throughout September, the NLA will lead a social media campaign... more
Multiple randomized controlled trials have demonstrated significant reductions in major cardiovascular (CV) events and mortality with statin therapy.(1) These data have supported the “LDL-C treatment strategy,” in which CV event risk reduction is directly proportionate to the extent of... more
.field.field-name-field-embargo.field-type-datetime.field-label-hidden, .field.field-name-field-rating.field-type-fivestar.field-label-inline.clearfix, .links{ display:none } .body_table li, .head_table li, .body_table p, .head_table p{ line-height: 20px... more
Introduction Symptomatic coronary atherosclerosis is rare in women under age 40, even when conventional risk factors are present. This “athero-protection” has been attributed to the female “hormonal advantage” during premenopausal years. However, it has been speculated that other, non-hormonal X... more